F. Charles Brunicardi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia”.

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia

International Journal of Molecular Sciences(2020)10.3390/ijms21228823

N/A

0DataRank · unranked

22 citations

Khaled Alganem, Ali Sajid Imami, Nicholas Henkel, F. Charles Brunicardi, Shi‐He Liu +5 more

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases

International Journal of Molecular Sciences(2020)10.3390/ijms21228679

N/A

0DataRank · unranked

40 citations

Khaled Alganem, Ali Sajid Imami, F. Charles Brunicardi, Shi‐He Liu, Rammohan Shukla +4 more

Data from Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

(2023)10.1158/1535-7163.c.6531150

N/A

0DataRank · unranked

0 citations

Uddalak Bharadwaj, Rongxin Zhang, Sheng Zhang, Hong Mu, William E. Fisher +4 more

Data from Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

(2023)10.1158/1535-7163.c.6531150.v1

N/A

0DataRank · unranked

0 citations

Uddalak Bharadwaj, Rongxin Zhang, Sheng Zhang, Hong Mu, William E. Fisher +4 more

Smart exosomes enhance PDAC targeted therapy

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.02.037

N/A

0DataRank · unranked

54 citations

Jonathan Sevier, Jian‐Ting Zhang, Yakov Lapitsky, F. Charles Brunicardi, Ge Jin +6 more